Twitter universal website tag code Twitter website tag code

[Skip to content]

Private hospital continually investing in advanced diagnostic and treatment technologies
Search our Site

Nuclear Medicine Hosahalli Mohan, Private Clinic Treatment, Self Pay Patients

Dedicated GP referral service

Call Cromwell Direct to make a referral on

+44 (0)800 783 9229

More about Cromwell Direct

Make a referral

Refer a patient to us by telephone, fax or email

How to refer

Make an appointment

8am-8pm Monday to Friday
8am-2pm Saturday
Call our Contact Centre on

+44 (0)20 7460 5700

Contact Us

Dr Hosahalli Mohan, Consultant in Nuclear Medicine

Specialising in:

Nuclear medicine diagnostic imaging, hybrid imaging including PET/CT and SPECT/CT and radionuclide therapy of thyroid cancer, nueroendocrine cancer and bone pain palliation.

(Unnamed Fieldset)
Specialist Details
Full name

Dr Hosahalli Mohan

Qualifications

FRCP, MSc

Title

Consultant in Nuclear Medicine

Specialties

Nuclear Medicine, Paediatric Nuclear Medicine

Site specialisation
Site specialisation 2
Clinical interests

Nuclear medicine diagnostic imaging, hybrid imaging including PET/CT and SPECT/CT and radionuclide therapy of thyroid cancer, nueroendocrine cancer and bone pain palliation.

Background Information
Biography

Molecular imaging of drug resistanceDr Mohan has nearly 15 years of experience in the field of Nuclear medicine with a special interest in Radionuclide therapy and Molecular imaging of the disease using Multimodality Imaging. 
 
He is the lead physician in the post surgical management of thyroid cancer. He has extensive experience in the provision of high quality radionuclide therapy of Thyroid cancer, Neuroendocrine tumours, bone pain palliation and labelled antibody treatment in Lymphoma.

Languages spoken

English, Hindi, Urdu, Kannada, Tamil

Availability
Regular Cromwell clinics

No

Clinic days

Mon: Tue: Wed: Thurs: Fri: Sat:

Appointments telephone number

020 7460 5700

Additional Career Information
Year qualified

1995

Memberships

BMA, MPS, EANM, BNMS

NHS hospitals

Guy's & St Thomas' NHS Trust

Posts
Research interests

Molecular imaging of drug resistance.

Key published papers

Mohan HK, Routledge T, Cane P, Livieratos L, Ballinger JR, Peters AM. Does the Clearance of Inhaled 99mTc-Sestamibi Correlate with Multidrug Resistance Protein 1 Expression in the Human Lung? 
Radiology. 2016 Mar 7:151389. (Epub ahead of print) 
 
Agrawal K, Weaver J, Ul-Hassan F, Jeannon JP, Simo R, Carroll P, Hubbard JG, Chandra A, Mohan HK 
Incidence and Significance of Incidental Focal Thyroid Uptake on 18F-FDG PET Study in a Large Patient Cohort: Retrospective Single-Centre Experience in the United Kingdom. Eur Thyroid J 2015;4:115-122 
 
Malavika Nathan, Fahim-ul Hassan, Hosahalli K Mohan:  Advances in imaging in differentiated thyroid cancer: focus on SPECT/CT and PET/CT: Expert Review of Endocrinology and Metabolism, July 2011, Vol. 6, No. 4, Pages 599-616. 
 
Helyar V, Mohan HK, Barwick T, Livieratos L, Gnanasegaran G, Clarke SE, Fogelman I. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate. Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):706-13. Epub 2009 Dec 17. 
 
HK Mohan, KA Miles. Cost-Effectiveness of 99mTc-Sestamibi in Predicting Response to Chemotherapy in Patients with Lung Cancer: Systematic Review and Meta-Analysis. J Nucl Med. 2009 Mar;50(3):376-81

Website

Media coverage

Our health professionals regularly contribute to hospital publications, as well as national newspaper articles and television coverage.